Overview

Study of Exchange of Travoprost Intraocular Implant

Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the safety of the operative and surgical exchange procedure of Travoprost Intraocular Implant in subjects with open-angle glaucoma or ocular hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Glaukos Corporation
Treatments:
Travoprost